Three-year effectiveness of highly active antiretroviral treatment in the Luxembourg HIV cohort.

HIV clinical trials

Volumn 1, Issue 2, 2000, Pages 17-24

  Servais, J ^a   Schmit, J C ^a   Arendt, V ^a   Lambert, C ^a   Staub, T ^a   Robert, I ^a   Fontaine, E ^a   Plesseria J M ^a   Burgy, C ^a   Kirpach, P ^a   Schneider, F ^a   Hemmer, R ^a  

^a Retrovirology Laboratory Luxembourg   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LUXEMBOURG; MALE; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; LUXEMBOURG; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0034279014     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/FXCQ-1WET-CAH0-X62P     Document Type: Article

References (0)